Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey J Raizer

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Expert Review of Anticancer Therapy|March 24, 2015
Bevacizumab in high-grade gliomas: past, present, and futureRichard C Curry, Saurabh Dahiya, Vyshak Alva Venur, et al.
Neuro-Oncology|January 5, 2002
A phase II study of extended low-dose temozolomide in recurrent malignant gliomasRaja B Khan, Jeffrey J Raizer, Mark G Malkin, et al.
Journal of Neuro-Oncology|October 4, 2011
Metastatic glioblastoma: case presentations and a review of the literatureGauri Kalokhe, Sean A Grimm, James P Chandler, et al.
Frontiers in Oncology|June 2, 2020
The Impact of Perioperative Arterial Infarct on Recurrence, Functional Outcomes, and Survival in Glioblastoma PatientsJakob T Lupa, Jeffrey J Raizer, Irene B Helenowski, et al.
Journal of Neurosurgery|September 12, 2006
Oligodendroglioma of the pineal region. Case reportSunit Das, James P Chandler, Ania Pollack, et al.
Journal of Neuro-Oncology|June 20, 2003
Chordoid glioma: report of a case with unusual histologic features, ultrastructural study and review of the literatureJeffrey J Raizer, Teena Shetty, Philip H Gutin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 21, 2014
Development of a symptom index for patients with primary brain tumorsJin-Shei Lai, Sally E Jensen, Jennifer L Beaumont, et al.
Journal of Neuro-Oncology|November 8, 2007
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastasesFabio M Iwamoto, Antonio M Omuro, Jeffrey J Raizer, et al.
Journal of Neuro-Oncology|May 7, 2008
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysisNimish A Mohile, Peter Forsyth, Douglas Stewart, et al.
Journal of Neuro-Oncology|February 28, 2014
Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicityStephen F Futterer, Alexander J Nemeth, Sean A Grimm, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Expert Review of Anticancer Therapy|March 24, 2015
Bevacizumab in high-grade gliomas: past, present, and futureRichard C Curry, Saurabh Dahiya, Vyshak Alva Venur, et al.
Neuro-Oncology|January 5, 2002
A phase II study of extended low-dose temozolomide in recurrent malignant gliomasRaja B Khan, Jeffrey J Raizer, Mark G Malkin, et al.
Journal of Neuro-Oncology|October 4, 2011
Metastatic glioblastoma: case presentations and a review of the literatureGauri Kalokhe, Sean A Grimm, James P Chandler, et al.
Frontiers in Oncology|June 2, 2020
The Impact of Perioperative Arterial Infarct on Recurrence, Functional Outcomes, and Survival in Glioblastoma PatientsJakob T Lupa, Jeffrey J Raizer, Irene B Helenowski, et al.
Journal of Neurosurgery|September 12, 2006
Oligodendroglioma of the pineal region. Case reportSunit Das, James P Chandler, Ania Pollack, et al.
Journal of Neuro-Oncology|June 20, 2003
Chordoid glioma: report of a case with unusual histologic features, ultrastructural study and review of the literatureJeffrey J Raizer, Teena Shetty, Philip H Gutin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 21, 2014
Development of a symptom index for patients with primary brain tumorsJin-Shei Lai, Sally E Jensen, Jennifer L Beaumont, et al.
Journal of Neuro-Oncology|November 8, 2007
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastasesFabio M Iwamoto, Antonio M Omuro, Jeffrey J Raizer, et al.
Journal of Neuro-Oncology|May 7, 2008
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysisNimish A Mohile, Peter Forsyth, Douglas Stewart, et al.
Journal of Neuro-Oncology|February 28, 2014
Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicityStephen F Futterer, Alexander J Nemeth, Sean A Grimm, et al.
Pageof 8